NCT03160846

The Inotrope Evaluation and Research Patient Registry

Inotrope, Evaluation and Research (INTERPRET) Patient Registry Program

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 129 (actual)
• Sponsor: Coram Clinical Trials · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The INTERPRET Inotrope Evaluation and Research Patient Registry is a longitudinal, observational study designed to look at the demographics and outcomes of heart failure patients on inotropic therapy administered in the home or infusion suite setting. The data gathered in this registry will provide information on how a patient's quality of life and symptoms change over time while on inotrope therapy, and help healthcare providers to have a better understanding of the benefits and risks associated with bridge-to-treatment and palliative care.

Detailed description

Eligible patients will be consented by the site investigator or staff to participate in the Registry at the time of referral for home care. Clinical data, including dosing, symptom severity, lab values, and hospitalizations, along with data on quality-of-life and patient compliance with treatment, will be collected by the home care nurses and pharmacists. The Registry's goal is to significantly contribute to the medical understandings of heart failure treatment and to improve the quality of care for heart failure patients in the United States through active publication of registry findings and disease management approaches.

Conditions

• Heart Failure

Interventions

Type	Name	Description
DRUG	Inotrope	Home intravenous infusion of Dobutamine, Dopamine, or Milrinone

Timeline

• Start date: 2014-08-25
• Primary completion: 2021-09-30
• Completion: 2021-09-30
• First posted: 2017-05-19
• Last updated: 2022-06-22

Locations

5 sites across 1 country: United States